| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Expression profiling by array
|
Homo sapiens
|
CEL
|
Aug 01, 2016
|
||||
| GSE78282 |
Effect of LANA deletion on the host gene expression during de novo KSHV infection of SLK cells.
|
|
|
6 |
|
Zsolt Toth | Aug 01, 2016 | |
| GSE83118 |
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs [SPR899]
|
|
|
6 |
|
Richard Bourgon | Aug 01, 2016 | |
| GSE84908 |
Tacrolimus in diabetic nephropathy
|
|
|
8 |
|
Constantin Aschauer | Aug 01, 2016 | |
| GSE43769 |
Expression data from human Th1 and Th2 cells
|
|
|
12 |
|
David John Cousins | Aug 01, 2016 | |
| GSE56941 |
SPROUTY2 target genes in human colon carcinoma cells
|
|
|
12 |
|
Antonio Barbachano | Aug 01, 2016 | |
| GSE66606 |
Gene expression profiling of Calu-6 lung cancer cells transfected with scrambled siRNA and LAPTM4B-specific siRNA
|
|
|
12 |
|
Humam Kadara | Aug 01, 2016 | |
| GSE82224 |
Effects of SOCS2-AS1 inhibition in prostate cancer cells
|
|
|
12 |
|
Ken-ichi Takayama | Aug 01, 2016 | |
| GSE83120 |
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs [SPR1108]
|
|
|
12 |
|
Richard Bourgon | Aug 01, 2016 | |
| GSE83122 |
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs
|
|
|
18 |
|
Richard Bourgon | Aug 01, 2016 | |
| GSE81292 |
Expression of mRNA from lung tissue from Systemic Sclerosis patients with interstitial lung disease (SSc-ILD) and healthy controls (HC)
|
|
|
20 |
|
Romy B Christmann | Aug 01, 2016 | |
| GSE82225 |
Androgen-induced lncRNA SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells
|
|
|
26 | Ken-ichi Takayama | Aug 01, 2016 | ||
| GSE81294 |
Lung gene expression
|
|
|
40 |
|
Romy B Christmann | Aug 01, 2016 |
